Reaching LDL-c targets in high-risk patients requires high-efficacy cholesterol-lowering drugs in more than 50% of cases. the results of the CHECK study

Pharmacological Research

Volumn 64, Issue 4, 2011, Pages 393-396

  Poli, Andrea ^a   Casula, Manuela ^a   Tragni, Elena ^a   Brignoli, Ovidio ^b   Filippi, Alessandro ^b   Cricelli, Claudio ^b   Catapano, Alberico L ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b Italian Society of General Medicine SIMG   (Italy)

Author keywords

Cardiovascular disease; Cardiovascular risk; Cholesterol; HDL; LDL; Statins

Indexed keywords

ATORVASTATIN; EZETIMIBE PLUS SIMVASTATIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ROSUVASTATIN; SIMVASTATIN;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DRUG EFFICACY; DRUG SAFETY; DYSLIPIDEMIA; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK REDUCTION;

ADULT; AGED; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; CHOLESTEROL, LDL; COHORT STUDIES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; ITALY; MIDDLE AGED;

EID: 80052961704     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2011.06.017     Document Type: Article

References (15)

1. C. Baigent, A. Keech, P.M. Kearney, L. Blackwell, G. Buck, and C. Pollicino Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins Lancet 366 2005 1267 1278
2. F. Marangoni, and A. Poli Phytosterols and cardiovascular health Pharmacol Res 61 2010 193 199
3. C. Baigent, L. Blackwell, J. Emberson, L.E. Holland, C. Reith, and N. Bhala Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials Lancet 376 2010 1670 1681
4. S.M. Grundy, J.I. Cleeman, C.N. Merz, H.B. Brewer Jr., L.T. Clark, and D.B. Hunninghake Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines Circulation 110 2004 227 239 (Pubitemid 38924592)
5. I. Graham, D. Atar, K. Borch-Johnsen, G. Boysen, G. Burell, and R. Cifkova European guidelines on cardiovascular disease prevention in clinical practice: full text Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts) Eur J Cardiovasc Prev Rehabil 14 Suppl. 2 2007 S1 S113
6. Z.J. Zhang, Q. Cheng, G.X. Jiang, and O.C. Marroquin Statins in prevention of repeat revascularization after percutaneous coronary intervention - a meta-analysis of randomized clinical trials Pharmacol Res 61 2010 316 320
7. A. Poli, E. Tragni, M. Casula, A. Filippi, R. Diotti, and O. Brignoli How many patients need statin treatment in a low-cardiovascular-risk country? Low-density lipoprotein-cholesterol target and distance from target distribution in an Italian cohort Nutr Metab Cardiovasc Dis 2010
8. http://www.agenziafarmaco.it/it/content/nota-13 [accessed April 2011].
9. V.J. Carey, L. Bishop, N. Laranjo, B.J. Harshfield, C. Kwiat, and F.M. Sacks Contribution of high plasma triglycerides and low high-density lipoprotein cholesterol to residual risk of coronary heart disease after establishment of low-density lipoprotein cholesterol control Am J Cardiol 106 2010 757 763
10. L. Palmieri, S. Panico, D. Vanuzzo, M. Ferrario, L. Pilotto, and R. Sega Evaluation of the global cardiovascular absolute risk: the Progetto CUORE individual score Ann Ist Super Sanita 40 2004 393 399 (Pubitemid 40904325)
11. D.J. Jenkins, C.W. Kendall, D.A. Faulkner, T. Nguyen, T. Kemp, and A. Marchie Assessment of the longer-term effects of a dietary portfolio of cholesterol-lowering foods in hypercholesterolemia Am J Clin Nutr 83 2006 582 591 (Pubitemid 44699203)
12. J. Armitage, L. Bowman, K. Wallendszus, R. Bulbulia, K. Rahimi, and R. Haynes Intensive lowering of LDL cholesterol with 80 mg versus 20 mg simvastatin daily in 12,064 survivors of myocardial infarction: a double-blind randomised trial Lancet 376 2010 1658 1669
13. M.R. Law, N.J. Wald, and A.R. Rudnicka Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis BMJ 326 2003 1423
14. S.J. Nicholls, E.M. Tuzcu, I. Sipahi, A.W. Grasso, P. Schoenhagen, and T. Hu Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis JAMA 297 2007 499 508 (Pubitemid 46220805)
15. S.A. Grover, M. Kaouache, L. Joseph, P. Barter, and J. Davignon Evaluating the incremental benefits of raising high-density lipoprotein cholesterol levels during lipid therapy after adjustment for the reductions in other blood lipid levels Arch Intern Med 169 2009 1775 1780